Producer: Abbott Laboratories (Abbott Leboratoriz) Netherlands
Code of automatic telephone exchange: L03AX
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
Drug represents a polyvalent antigenic complex, mix of lysates of bacteria which composition corresponds to the activators which are the most often causing inflammatory proyotsessa in oral cavities and throats.
Имудон® (mix of lysates of bacteria)-2,7 mg (in terms of dry matter):
lysates of bacteria: [L. acidophilus + L. delbrueckii ss lactis + L. helveticus + L. fermentum + S. pyogenes groupe A + S. sanguis groupe H + S. aureus + E. faecium + E. faecalis + K. pneumoniae ss pneumoniae + F. nucleatum ss fusiforme + C. pseudodiphtheriticum + C. albicans]-0,1575 mg
glycine −2,0мг, sodium dezoksikholat-0,53 mg, tiomersat - not more than 0,0125 mg. Excipients:
glycine — 47,3 mg, lactoses monohydrate — 350 mg, Mannitolum — 100 mg, sodium saccharinate — 1,12 mg, povidone of 10,0 mg, Natrii hydrocarbonas of 30,0 mg, citric acid anhydrous — 23,0 mg, fragrance mint — 8,0 mg, magnesium stearate — 4,88 mg.
Tablets of white or almost white color, ploskotsilindrichesky form, with a smooth brilliant surface, with slanted edges, with a mint smell, the insignificant mramornost is allowed.
The immunostimulating drug of a bacterial origin for topical administration in otorhinolaryngology, stomatology. Activates phagocytosis, promotes increase in quantity of immunocompetent cells, increases development of a lysozyme and interferon, immunoglobulin A in saliva.
Indications to use:
Treatment and prevention of infectious and inflammatory diseases of an oral cavity and throat:
- adenoid disease;
- preoperative preparation and the postoperative period after a tonsilectomy;
- superficial and deep periodontosis, periodontal disease, stomatitis (including aphthous),
- erythematic and ulocace;
- oral cavity dysbacteriosis;
- infections after an exodontia, implantations of artificial tooth roots;
- the ulcerations caused by dentures.
Route of administration and doses:
For adults and teenagers 14 years are more senior.
At acute inflammatory diseases of an oral cavity and throat and an exacerbation of chronic diseases drug is accepted on 8 tablets a day. Tablets rassasyvat (without chewing) in an oral cavity at an interval of 1-2 hours. The average duration of a course of treatment is 10 days.
For prevention of an exacerbation of chronic inflammatory diseases of an oral cavity and a throat drug is accepted on 6 tablets a day. Tablets rassasyvat (without chewing) in an oral cavity at an interval of the 2nd hour. Duration of a course is 20 days. 3-4 times a year are recommended to conduct preventive courses of treatment Imudon.
For children from 3 to 14 years.
At treatment acute and an exacerbation of chronic inflammatory diseases of an oral cavity and throat, and also for prevention drug is used on 6 tablets a day. Tablets rassasyvat (without chewing) in an oral cavity at an interval of 1-2 hours. Duration of a course of treatment at acute diseases of 10 days, for prevention of an exacerbation of chronic diseases — 20 days. The course of preventive use is recommended to repeat 3-4 times a year.
Features of use:
Children from 3rd to 6 years rassasyvat tablets under obligatory supervision of adults!
It is not necessary to eat food and water, and also to rinse a mouth within an hour after use
Imudona, not to reduce a therapeutic effectiveness of drug.
At purpose of drug the patients keeping to an electrolyte-deficient or light-salted diet need to consider that 1 tablet of Imudon contains 15 mg of Na+.
the patient with bronchial asthma who have an administration of drugs containing bacterial lysates, causes an exacerbation of a disease (an attack of bronchial asthma), it is not recommended to use drug.
Influence on ability to driving and other mechanisms
There are no data testimonial of need of any restrictions of the activity connected with driving or other mechanisms during treatment.
In rare instances use of drug can be followed by allergic reactions (rash, urticaria, a Quincke's disease), reactions from digestive tract (nausea, vomiting, abdominal pains), temperature increase, an exacerbation of bronchial asthma, cough. Seldom or never use of drug can be followed by development of a knotty erythema, hemorrhagic vasculitis, thrombocytopenia.
Interaction with other medicines:
It is noted. Имудон® it can be used with medicines of other groups.
The increased individual sensitivity to drug or its components;
children's age up to 3 years;
Period of pregnancy and lactation
Information on use Imudona at pregnant women is insufficient. The relevant data of experiments on animals and epidemiological researches are absent.
Imudon during pregnancy or a lactation is not recommended to accept.
Cases of overdose of Imudon are not described.
Store and transport according to the joint venture 18.104.22.1688-03 at a temperature not above 25 °C. To store in the place, unavailable to children. Period of validity 2 years.
According to the recipe
On 8 tablets in a blister strip packaging (blister) from composition material polyamide/aluminium/PVC and the printing aluminum foil varnished.
3 or 5 blister strip packagings (blisters) on 8 tablets together with the application instruction place in a pack from a cardboard.